Table 1.
TAG^& | DAG | ChE | CL | LyPC | PC | PE | PS | SM | ||
---|---|---|---|---|---|---|---|---|---|---|
Day 1 | CON | 16.7 ± 2.1 | 3.9 ± 0.4 | 4.0 ± 0.3 | 3.2 ± 0.3 | 1.6 ± 0.1 | 27.2 ± 3.0 | 15.0 ± 0.3 | 3.3 ± 0.3 | 1.5 ± 0.04 |
CE | 24.1 ± 2.2* | 4.7 ± 0.4 | 4.7 ± 0.4 | 3.2 ± 0.4 | 1.5 ± 0.1 | 21.9 ± 2.0 | 14.4 ± 0.3 | 3.2 ± 0.2 | 1.4 ± 0.1 | |
HIIE | 32.5 ± 3.9*# | 4.8 ± 0.4 | 4.2 ± 0.2 | 3.0 ± 0.2 | 1.6 ± 0.2 | 22.6 ± 1.6 | 15.0 ± 0.4 | 3.2 ± 0.1 | 1.4 ± 0.03 | |
Day 2 | CON | 6.7 ± 0.8 | 2.2 ± 0.2 | 3.5 ± 0.1 | 3.6 ± 0.5 | 1.3 ± 0.1 | 25.4 ± 2.5 | 13.4 ± 0.4 | 2.7 ± 0.2 | 1.3 ± 0.03 |
CE | 6.2 ± 0.9 | 1.8 ± 0.1 | 3.5 ± 0.2 | 3.0 ± 0.1 | 1.4 ± 0.1 | 25.1 ± 2.5 | 13.5 ± 0.2 | 3.0 ± 0.4 | 1.4 ± 0.1 | |
HIIE | 8.5 ± 1.2 | 2.7 ± 0.4 | 4.1 ± 0.3 | 2.9 ± 0.04 | 1.4 ± 0.1 | 25.6 ± 0.9 | 14.0 ± 0.6 | 2.4 ± 0.1 | 1.3 ± 0.1 |
Values are total content, expressed as μmol of esterified lipid per gram of liver wet weight. n = 6 per group. TAG Triacylglycerol, DAG Diacylglycerol, ChE Cholesterol ester, CL Cardiolipin, LyPC Lysophosphatidylcholine, PC Phosphatidylcholine, PE Phosphatidylethanolamine, PS Phosphatidylserine, SM Sphingomyelin. Day 1: 3 h after exercise. Day 2: 28 h following exercise. Statistics by ANOVA. ^Main effect of trial, P < 0.05. &Trial-by-time interaction, P < 0.05. *Significantly different from CON within Day 1, p < 0.05. #Significantly different from CE within Day 1, P < 0.05